COVID-19 Policies
Issuance Date Title
Department Memorandum 2021-0223 May 06, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0197 April 19, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0175 April 08, 2021 Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation
Department Circular 2021-0122 April 05, 2021 Reiteration of Prevention, Detection, Isolation, Treatment, and Reintegration (PDITR) Strategies for COVID-19 in Light of the Implementation of Enhance Community Quarantine in NCR Plus Bubble
Department Circular 2021-0118 March 31, 2021 Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week
Department Memorandum 2021-0161 March 31, 2021 Interim Guidelines for the Conduct of Saliva-Based RT-PCR Testing for the Detection of SARS Cov-2
Department Memorandum 2021-0157 March 30, 2021 Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
Department Memorandum 2021-0169 March 29, 2021 Interim Guidelines on Rapid Antigen Test Reporting for the NCR Plus Bubble
DOH-NTF Joint Adminsitrative Order 2021-0001 March 26, 2021 Implementing Rules and Regulations of Republic Act No. 11525 known as "An Act Establishing the COVID-19 Vaccination Program Expediting the Vaccine Procurement and Administation Process, Providing Funds Therefor, and For Other Purposes
Department Circular 2021-0101 March 11, 2021 Clarification on Provisions of Department Memorandum 2021-0099 entitled the "Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19"
Department Memorandum 2021-0123 March 04, 2021 Interim Guidelines for the Management and Administration of the AstraZeneca (ChAdOx1-S [recombinant]) COVID-19 Vaccine
Department Memorandum 2021-0116 February 26, 2021 Interim Guidelines on the Identification and Utilization of COVID-19 Vaccination Sites

Pages